Effects of ellagic acid pretreatment on renal functions disturbances induced by global cerebral ischemic-reperfusion in rat

Document Type : Original Article


1 Abadan Arvand International Division, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

2 Physiology Research Center and Department of Physiology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran


Objective(s): Global cerebral ischemia-reperfusion (GCIR) causes disturbances in brain functions as well as other organs such as kidney. Our aim was to evaluate the protective effects of ellagic acid (EA) on certain renal disfunction after GCIR.
Materials and Methods: Adult male Wistar rats (n=32, 250-300 g) were used. GCIR was induced by bilateral vertebral and common carotid arteries occlusion (4-VO). Animal groups were: 1) received DMSO/saline (10%) as solvent of EA, 2) solvent + GCIR, 3) EA + GCIR, and 4) EA. Under anesthesia with ketamine/xylazine, GCIR was induced (20 and 30 min respectively) in related groups. EA (100 mg/kg, dissolved in DMSO/saline (10%) or solvent was administered (1.5 ml/kg) orally for 10 consecutive days to the related groups. EEG was recorded from NTS in GCIR treated groups.
Results: Our data showed that: a) EEG in GCIR treated groups was flattened. b) GCIR reduced GFR (P<0.01) and pretreatment with EA attenuated this reduction. c) BUN was increased by GCIR (P<0.001) and pretreatment with EA improved the BUN to normal level. d) Serum creatinine concentration was elevated by GCIR but not significantly, however, in EA+GCIR group serum creatinine was reduced (P<0.05). e) GCIR induced proteinuria (P<0.05) but, EA was unable to reduced proteinuria.
Conclusion: Results indicate that GCIR impairs certain renal functions and EA as an antioxidant can improve these functions. Our results suggest the possible usefulness of ellagic acid in patients with brain stroke.


1. Mendis S, Norrving B. Organizational update: World Health Organization. Stroke 2014; 45:e22-e23.
2. Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, GutteridgeG, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002; 346:557-563.
3. Sanada S, Komuro I, Kitakaze M. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning and translational aspects of protective measures. Am J Physiol Heart Circ Physiol 2011; 301:H1723-H1741.
4. Sottiurai VS, Herbert L, Hatter D. Revascularization of cerebral ischemia after previous bilateral extracranial-intracranial bypass procedures. J Vasc Surg 1997; 26:160-163.
5. Klein KU, Stadie A, Fukui K, Schramm P, Werner C, Oertel J, et al. Measurement of cortical microcirculation during intracranial aneurysm surgery by combined laser-Doppler flowmetry and photospectrometry. Neurosurgery 2011; 69:391-398.
6. Liu AJ, Ling G, Wu J, Shen FM, Wang DS, Lin LL, et al. Arterial baroreflex function is an important determinant of acute cerebral ischemia in rats with middle cerebral artery occlusion. Life Sci 2008; 83 388-393.
7. Tracey KJ. Physiology and immunology of the cholinergic anti-inflammatory pathway. J Clin Invest 2007; 117:289-296.
8. Min J, Farooq MU, Greenberg E, Aloka F, Bhatt A, Kassab M, et al. Cardiac dysfunction after left permanent cerebral focal ischemia: the brain and heart connection. Stroke 2009; 40:2560-2563.
9. O'Donnell MJ, Kapral MK, Fang J, Saposnik G, Eikelboom JW, Oczkowski W, et al. Gastrointestinal bleeding after acute ischemic stroke. Neurology 2008; 71:650-655.
10. Yao H, Sadoshima S, Shiokawa O, Fujii K, Fujishima M. Renal blood flow in acute cerebral ischemia in spontaneously hypertensive rats: effects of alpha- and beta-adrenergic blockade. Stroke 1987; 18:629-633.
11. Yun X, Maximov VD, Yu J, Zhu H, Vertegel AA, Kindy MS. Nanoparticles for targeted delivery of antioxidant enzymes to the brain after cerebral ischemia and reperfusion injury. J Cereb Blood Flow Metab 2013; 33:583-592.
12. Soong YY, Barlow PJ. Quantification of gallic acid and ellagic acid from longan (Dimocarpus longan Lour.) seed and mango (Mangifera indica L.) kernel and their effects on antioxidant activity. Food Chem 2006; 97:524-530.
13. Hassoun EA, Vodhanel J, Abushaban A. The modulatory effects of ellagic acid and vitamin E succinate on TCDD-induced oxidative stress in different brain regions of rats after subchronic exposure. J Biochem Mol Toxicol 2004; 18:196-203.
14. Matsui I, Hamano T, Tomida K, Inoue K, Takabatake Y, Nagasawa Y, et al. Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in rats. Nephrol Dial Transplant 2009; 24:2354-2361.
15. Yonekura I, Kawahara N, Nakatomi H, Furuya K, Kirino T. A model of global cerebral ischemia in C57 BL/6 mice. J Cereb Blood Flow Metab 2004; 24:151-158.
16. Girish C, Koner BC, Jayanthi S, Ramachandra RK, Rajesh B, Pradhan SC. Hepatoprotective activity of picroliv, curcumin and ellagic acid compared to silymarin on paracetamol induced liver toxicity in mice. Fundam Clin Pharmacol 2009; 23:735-745.
17. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 6th ed. Amsterdam. Boston: Academic Press/Elsevier; 2007.
18. Pulsinelli WA, Brierley JB. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 1979; 10:267-272.
19. Kleinschnitz C, Kraft P, Dreykluft A, Hagedorn I, Göbel K, Schuhmann MK, et al. Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood 2013; 121:679-691.
20. Yamaguchi M, Calvert JW, Kusaka G, Zhang JH. One-stage anterior approach for four-vessel occlusion in rat. Stroke 2005; 36:2212-2214.
21. Heinel LA, Rubin S, Rosenwasser RH, Vasthare US, Tuma RF. Leukocyte involvement in cerebral infarct generation after ischemia and reperfusion. Brain Res Bull 1994; 34:137-141.
22. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999; 79:1431-1568.
23. Williams FM. Role of neutrophils in reperfusion injury. In: Hellewell PG, Williams TJ. editors. Immunopharmacology of Neutrophils. London: Academic Press; 1994. p.245-257.
24. Finkel T. Oxygen radicals and signaling, Curr Opin Cell Biol 1998; 10:248-253.
25. Matsuo Y, Onodera H, Shiga Y, Shozuhara H, Ninomiya M, Kihara T, et al. Role of cell adhesion molecules in brain injury after transient middle cerebral artery occlusion in the rat. Brain Res 1994; 656: 344-352.
26. Lew PD, Wolheim CB, Waldvogel FA, Pozzan T. Modulation of cytosolic free calcium transients by changes in intra-cellular calcium buffering capacity; correlation with exocytosis and O2 production inhuman neutrophils. J Cell Biol 1984; 99:1212-1220.
27. Fabian RH, Kent TA. Superoxide anion production during reperfusion is reduced by an anti-neutrophil antibody after prolonged cerebral ischemia. Free Radic Biol Med 1999; 26:355-361.
28. Littleton-Kearney MT, Hurn PD, Kickler TS, Traystman RJ. Incomplete global cerebral ischemia alters platelet biology in neonatal and adult sheep. Am J Physiol 1998; 274:1293-1300.
29. Gremmel T, Müller M, Steiner S, Seidinger D, Koppensteiner R, Kopp CW, et al. Chronic kidney disease is associated with increased platelet activation and poor response to antiplatelet therapy. Nephrol Dial Transplant 2013; 28:2116-2122.
30. Vlădăreanu AM, Popov V, Radeşi S, Onisâi M, Bumbea H. Role of reactive oxygen species in platelet function in normal states and chronic myeloproliferative disorders. Rom J Bioch 2008; 45:221–232.
31. Au R, Massaro JM, Wolf PA, Young ME, Beiser A, Seshadri S, et al. Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. Arch Neurol 2006; 63:246-250.
32. O’Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 2005; 46:200-204.
33. Wong TY, Coresh J, Klein R, Muntner P, Couper DJ, Sharrett AR, et al. Retinal microvascular abnormalities and renal dysfunction: the atherosclerosis risk in communities study. J Am Soc Nephrol 2004; 15:2469-2476.
34. Schnackenberg CG. Physiological and patho-physiological roles of oxygen radicals in the renal microvasculature. Am J Physiol Regul Integr Comp Physiol 2002; 282:R335-R342.
35. Aronowski J, Strong R, Grotta JC. Reperfusion injury: demonstration of brain damage produced by reperfusion after transient focal ischemia in rats. J Cereb Blood Flow Metab1997; 17:1048-1056.
36. Saad MA, Abbas AM, Boshra V, Elkhateeb M, El Aal IA. Effect of angiotensin II type 1 receptor blocker, candesartan, and beta 1 adrenoceptor blocker, atenolol, on brain damage in ischemic stroke. Acta Physiol Hung 2010; 97:159-171.
37. Hojs Fabjan T, Penko M, Hojs R. Cystatin C, creatinine, estimated glomerular filtration, and long-term mortality in stroke patients. Ren Fail 2014; 36:81-86.
38. Long DA, Price KL, Herrera-Acosta J, Johnson RJ.How does angiotensin II cause renal injury? Hypertension 2004; 43:722-723.
39. Radermacher J, Haller H. The right diagnostic work-up: investigating renal and renovascular disorders. J Hypertens Suppl 2003; 21:S19-S24.
40. Aktoz T, Aydogdu N, Alagol B, Yalcin O, Huseyinova G, Atakan IH. The protective effects of melatonin and vitamin E against renal ischemia-reperfusion injury in rats. Ren Fail 2007; 29:535-542.
41. Savas M, Yeni E, Ciftci H, Yildiz F, Gulum M, Keser BS, et al. The antioxidant role of oral administration of garlic oil on renal ischemia-reperfusion injury. Ren Fail 2010; 32:362-367.
42. Seeram NP, Adams LS, Henning SM, Niu Y, Zhang Y, Nair MG, et al. In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutr Biochem 2005; 16:360-367.
43. Iino T, Nakahara K, Miki W, Kiso Y, Ogawa Y, Kato S, et al. Less damaging effect of whisky in rat stomachs in comparison with pure ethanol. Role of ellagic acid, the nonalcoholic component. Digestion 2001; 64:214-221.
44. Tian L, Shi MM, Forman HJ. Increased transcription of the regulatory subunit of γ-glutamylcysteine synthase in rat lung epithelial L2 cells exposed to oxidative stress or glutathione depletion. Arch Biochem Biophys 1997; 342:126-133.
45. Attilio P, Merritt C, Sims J, Kane N, O'Sullivan J. The effect of ellagic acid on platelet activation as measured by the quantification of P-selectin using flow cytometry. AANA J 2010; 78:453-459.
46. Pang X, Li T, Feng L, Zhao J, Zhang X, Liu J. Ellagic acid-induced thrombotic focal cerebral ischemic model in rats. J Pharmacol Toxicol Methods 2014; 69:217-222.
47. Hoseiny Nejad K, Dianat M, Sarkaki AR, Gharib Naseri MK, Badavi M, Farbood Y. Ellagic acid improves electrocardiogram waves and blood pressure against global cerebral ischemia rat experimental models. Electron Phys 2015; 7:1153-1162.
48. Sasaki Y, Iwama R, Sato T, Heishima K, Shimamura S, Ichijo T, et al. Estimation of glomerular filtration rate in conscious mice using a simplified equation. Physiol Rep 2014; 2:e12135.
49. Al-Kharusi N, Babiker HA, Al-Salam S, Waly MI, Nemmar A, Al-Lawati I, et al. Ellagic acid protects against cisplatin-induced nephrotoxicity in rats: a dose-dependent study. Eur Rev Med Pharmacol Sci 2013; 17: 299-310.
50. Sadick M, Attenberger U, Kraenzlin B, Kayed H, Schoenberg SO, Gretz N, et al. Two non-invasive GFR-estimation methods in rat models of polycystic kidney disease: 3.0 Tesla dynamic contrast-enhanced MRI and optical imaging. Nephrol Dial Transplant 2011; 26:3101-3108.
51. Ateşşahín A, Ceríbaşi AO, Yuce A, Bulmus O, Cikim G. Role of ellagic acid against cisplatin-induced nephrotoxicity and oxidative stress in rats. Basic Clin Pharmacol Toxicol 2007; 100:121-126.
52. Ovbiagele B, Liebeskind DS, Pineda S, Saver JL. Strong independent correlation of proteinuria with cerebral microbleeds in patients with stroke and transient ischemic attack. Arch Neurol 2010; 67:45-50.
53. Singh A, Ramnath RD, Foster RR, Wylie EC, Fridén V, Dasgupta I, et al. Reactive oxygen species modulate the barrier function of the human glomerular endothelial glycocalyx. PLoS One 2013; 8:e55852.
54. Maezawa Y, Takemoto M, Yokote K. Cell biology of diabetic nephropathy: roles of endothelial cells, tubulointerstitial cells and podocytes. J Diabetes Investig 2015; 6:3-15.
55. Liu YG, Li FJ, Wang J, Wang XD. Effects of ginkgolide B on inflammation induced by cerebral ischemia-reperfusion in rats. Zhong Yao Cai 2010; 33:578-580.
56. El-Garhy AM, Abd El-Raouf OM, El-Sayeh BM, Fawzy HM, Abdallah DM. Ellagic acid antiinflammatory and antiapoptotic potential mediate renoprotection in cisplatin nephrotoxic rats. J Biochem Mol Toxicol 2014; 28:472-479.
57. Cornélio Favarin D, Martins Teixeira M, Lemos de Andrade E, de Freitas Alves C, Lazo Chica JE, ArtérioSorgi C, et al. Anti-inflammatory effects of ellagic acid on acute lung injury induced by acid in mice. Mediators Inflamm 2013; 164202.